Champions Oncology Inc (CSBR) — Capital Reinvestment Ratio

Latest as of July 2025: 0.08x

Champions Oncology Inc (CSBR) has a Capital Reinvestment Ratio of 0.08x as of July 2025, meaning it reinvests 0% of its operating cash flow ($600.00K) in capital expenditures ($46.00K). Check tangible net worth ratio of Champions Oncology Inc to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.08x
Capex / Operating Cash Flow

Operating Cash Flow

$600.00K
USD

Capital Expenditures

$46.00K
USD

Data as of

Jul 2025
Most recent filing

Champions Oncology Inc Capital Reinvestment Ratio (1997–2025)

This chart tracks Champions Oncology Inc's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see Champions Oncology Inc cash conversion from operations.

Annual Capital Reinvestment Ratio for Champions Oncology Inc (1997–2025)

Year-by-year Capital Reinvestment Ratio for Champions Oncology Inc from 1997 to 2025. See CSBR FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.05x $7.39 Million $389.00K ▼ -92.7%
2023 0.73x $3.96 Million $2.87 Million ▲ +97.9%
2022 0.37x $6.50 Million $2.38 Million ▼ -52.0%
2020 0.76x $2.90 Million $2.22 Million ▲ +70.6%
2019 0.45x $1.86 Million $834.00K ▲ +92.2%
2001 0.23x $144.68K $33.72K ▲ +156.4%
1999 0.09x $110.00K $10.00K ▲ +90.9%
1998 0.05x $420.00K $20.00K ▼ -47.6%
1997 0.09x $110.00K $10.00K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow